Synopsis
Synopsis
0
USDMF
0
CEP/COS
0
JDMF
0
EU WC
0
KDMF
0
VMF
0
EDQM
0
USP
0
JP
0
Others
0
Europe
0
Canada
0
Australia
0
South Africa
0
Listed Dossiers
DRUG PRODUCT COMPOSITIONS
US Medicaid
NA
Annual Reports
NA
Regulatory FDF Prices
NA
0
API
0
FDF
0
Weekly News Recap #Phispers
1. 1-(3.alpha.-hydroxy-3.beta.-methyl-20-oxo-19-nor-5.beta.-pregnan-21-yl)-1h-pyrazole-4-carbonitrile
2. 1h-pyrazole-4-carbonitrile, 1-((3.alpha.,5.beta.)-3-hydroxy-3-methyl-20-oxo-19-norpregnan-21-yl)-
3. 3alpha-hydroxy-3beta-methyl-21-(4-cyano-1h-pyrazol-1'-yl)-19-nor-5beta-pregnan-20-one
4. 3beta-methyl-21-(4-cyano-1h-pyrazol-1'-yl)-19-norpregnanolone
5. Sage-217
1. Sage-217
2. 1632051-40-1
3. Zuranolone [inn]
4. Zuranolone [usan]
5. Sge-797
6. Chembl4105630
7. 7zw49n180b
8. S-812217
9. 1-[2-[(3r,5r,8r,9r,10s,13s,14s,17s)-3-hydroxy-3,13-dimethyl-2,4,5,6,7,8,9,10,11,12,14,15,16,17-tetradecahydro-1h-cyclopenta[a]phenanthren-17-yl]-2-oxoethyl]pyrazole-4-carbonitrile
10. Zuranolonesage-217
11. Zuranolone (usan/inn)
12. Unii-7zw49n180b
13. Schembl16189866
14. Dtxsid601128500
15. Glxc-15028
16. Amy27908
17. Ex-a1880
18. Bdbm50258216
19. Who 10896
20. Akos037648887
21. Db15490
22. Ac-35591
23. Bs-15950
24. Hy-103040
25. Cs-0023489
26. D11793
27. D80690
28. A905859
29. 3beta-methyl-21-(4-cyano-1h-pyrazol-1'-yl)-19-norpregnanolone
30. 3alpha-hydroxy-3beta-methyl-21-(4-cyano-1h-pyrazol-1'-yl)-19-nor-5beta-pregnan-20-one
31. 1-(2-((3r,5r,8r,9r,10s,13s,14s,17s)-3-hydroxy-3,13-dimethylhexadecahydro-1h-cyclopenta[a]phenanthren-17-yl)-2-oxoethyl)-1h-pyrazole-4-carbonitrile
32. 1-(2-((3r,5r,8r,9r,10s,13s,14s,17s)-3-hydroxy-3,13-dimethylhexadecahydro-1h-cyclopenta[a]phenanthren-17-yl)-2-oxoethyl)-1h-pyrazole-4-carbonitrile;1-[(3alpha,5beta)-3-hydroxy-3-methyl-20-oxo-19-norpregnan-21-yl]-1h-pyrazole-4-carbonitrile
33. 1-(3.alpha.-hydroxy-3.beta.-methyl-20-oxo-19-nor-5.beta.-pregnan-21-yl)-1h-pyrazole-4-carbonitrile
34. 1-(3alpha-hydroxy-3beta-methyl-20-oxo-19-nor-5beta-pregnan-21-yl)-1h-pyrazole-4-carbonitrile
35. 1h-pyrazole-4-carbonitrile, 1-((3.alpha.,5.beta.)-3-hydroxy-3-methyl-20-oxo-19-norpregnan-21-yl)-
36. 1h-pyrazole-4-carbonitrile, 1-((3alpha,5beta)-3-hydroxy-3-methyl-20-oxo-19-norpregnan-21-yl)-
Molecular Weight | 409.6 g/mol |
---|---|
Molecular Formula | C25H35N3O2 |
XLogP3 | 4.5 |
Hydrogen Bond Donor Count | 1 |
Hydrogen Bond Acceptor Count | 4 |
Rotatable Bond Count | 3 |
Exact Mass | 409.27292737 g/mol |
Monoisotopic Mass | 409.27292737 g/mol |
Topological Polar Surface Area | 78.9 Ų |
Heavy Atom Count | 30 |
Formal Charge | 0 |
Complexity | 746 |
Isotope Atom Count | 0 |
Defined Atom Stereocenter Count | 8 |
Undefined Atom Stereocenter Count | 0 |
Defined Bond Stereocenter Count | 0 |
Undefined Bond Stereocenter Count | 0 |
Covalently Bonded Unit Count | 1 |
Patents & EXCLUSIVITIES
ABOUT THIS PAGE
62
PharmaCompass offers a list of Zuranolone API manufacturers, exporters & distributors, which can be sorted by GMP, USDMF, JDMF, KDMF, CEP (COS), WC, Price,and more, enabling you to easily find the right Zuranolone manufacturer or Zuranolone supplier for your needs.
Send us enquiries for free, and we will assist you in establishing a direct connection with your preferred Zuranolone manufacturer or Zuranolone supplier.
PharmaCompass also assists you with knowing the Zuranolone API Price utilized in the formulation of products. Zuranolone API Price is not always fixed or binding as the Zuranolone Price is obtained through a variety of data sources. The Zuranolone Price can also vary due to multiple factors, including market conditions, regulatory modifications, or negotiated pricing deals.
A Zuranolone manufacturer is defined as any person or entity involved in the manufacture, preparation, processing, compounding or propagation of Zuranolone, including repackagers and relabelers. The FDA regulates Zuranolone manufacturers to ensure that their products comply with relevant laws and regulations and are safe and effective to use. Zuranolone API Manufacturers are required to adhere to Good Manufacturing Practices (GMP) to ensure that their products are consistently manufactured to meet established quality criteria.
click here to find a list of Zuranolone manufacturers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PhamaCompass.
A Zuranolone supplier is an individual or a company that provides Zuranolone active pharmaceutical ingredient (API) or Zuranolone finished formulations upon request. The Zuranolone suppliers may include Zuranolone API manufacturers, exporters, distributors and traders.
click here to find a list of Zuranolone suppliers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PharmaCompass.
National Drug Code is a comprehensive database maintained by the FDA that contains information on all drugs marketed in the US. This directory includes information about finished drug products, unfinished drug products, and compounded drug products, including those containing Zuranolone as an active pharmaceutical ingredient (API).
The FDA updates the NDC directory daily. The NDC numbers for Zuranolone API and other APIs are published in this directory by the FDA.
The NDC unfinished drugs database includes product listing information submitted for all unfinished drugs, such as active pharmaceutical ingredients (APIs), drugs intended for further processing and bulk drug substances for compounding.
Pharmaceutical companies that manufacture Zuranolone as an active pharmaceutical ingredient (API) must furnish the FDA with an updated record of all drugs that they produce, prepare, propagate, compound, or process for commercial distribution in the US at their facilities.
The NDC directory also contains data on finished compounded human drug products that contain Zuranolone and are produced by outsourcing facilities. While these outsourcing facilities are not mandated to assign a Zuranolone NDC to their finished compounded human drug products, they may choose to do so.
click here to find a list of Zuranolone suppliers with NDC on PharmaCompass.
Zuranolone Active pharmaceutical ingredient (API) is produced in GMP-certified manufacturing facility.
GMP stands for Good Manufacturing Practices, which is a system used in the pharmaceutical industry to make sure that goods are regularly produced and monitored in accordance with quality standards. The FDA’s current Good Manufacturing Practices requirements are referred to as cGMP or current GMP which indicates that the company follows the most recent GMP specifications. The World Health Organization (WHO) has its own set of GMP guidelines, called the WHO GMP. Different countries can also set their own guidelines for GMP like China (Chinese GMP) or the EU (EU GMP).
PharmaCompass offers a list of Zuranolone GMP manufacturers, exporters & distributors, which can be sorted by USDMF, JDMF, KDMF, CEP (COS), WC, API price, and more, enabling you to easily find the right Zuranolone GMP manufacturer or Zuranolone GMP API supplier for your needs.
A Zuranolone CoA (Certificate of Analysis) is a formal document that attests to Zuranolone's compliance with Zuranolone specifications and serves as a tool for batch-level quality control.
Zuranolone CoA mostly includes findings from lab analyses of a specific batch. For each Zuranolone CoA document that a company creates, the USFDA specifies specific requirements, such as supplier information, material identification, transportation data, evidence of conformity and signature data.
Zuranolone may be tested according to a variety of international standards, such as European Pharmacopoeia (Zuranolone EP), Zuranolone JP (Japanese Pharmacopeia) and the US Pharmacopoeia (Zuranolone USP).